December 21 Drugs & Diseases On the Shelf Dancing to the beet PT December 2022 Beetroot juice is well-known in the sports community as a postworkout must and performance enhancer. Mickie Cathers
December 21 Drugs & Diseases New Drug Approval of new ALS drug comes with controversy PT December 2022 After 5 years with no breakthroughs for patients living with amyotrophic lateral sclerosis (ALS), FDA has approved a new oral treatment called Relyvrio from Amylyx Pharmaceuticals. Lauren Howell, PharmD
December 21 Drugs & Diseases Alzheimer Disease Eisai to seek FDA approval for lecanemab, one of dozens of drugs in the Alzheimer pipeline PT December 2022 This fall, biotech Biogen and pharmaceutical company Eisai released topline data on their new antiamyloid monoclonal antibody le-canemab. Sonya Collins
December 21 Drugs & Diseases Biosimilars Ten Humira biosimilars headed to market in 2023 PT December 2022 At least 7 biosimilars for adalimumab (Humira–AbbVie, Inc.) are expected to hit the market in 2023. Sonya Collins
December 21 Drugs & Diseases Diabetes What additional medications might be best for patients taking metformin? PT December 2022 Two recently published articles in the New England Journal of Medicine looked at the comparative efficacy of different medications for the treatment of type 2 diabetes. Johanna Taylor Katroscik, PharmD
January 5 Drugs & Diseases New & Approved New Indications PT January 2023 Ioflupane i 123, Levonorgestrel, Pemetrexed.
January 5 Drugs & Diseases OTCs Today Cool that heartburn PT January 2023 Heartburn is a very common gastrointestinal complaint, often described as a burning sensation in the chest. Mary Warner
January 5 Drugs & Diseases On the Shelf Evening primrose oil PT January 2023 Best known for treating inflammation, evening primrose oil (EPO) has been a popular supplement for centuries used to address a host of conditions. Mickie Cathers
January 5 Drugs & Diseases Antidepressants & Depression USPSTF recommends anxiety screening for youth PT January 2023 The US Preventive Services Task Force (USPSTF) now recommends that children and adolescents should be screened for anxiety. Johanna Taylor Katroscik, PharmD
January 5 Drugs & Diseases Antidepressants Antidepressant use in pregnancy comes more into focus PT January 2023 Studying antidepressant use in pregnancy has led to an abundance of research, but without many answers. Loren Bonner